These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 9918559

  • 1. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
    Raap DK, Garcia F, Muma NA, Wolf WA, Battaglia G, van de Kar LD.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
    [Abstract] [Full Text] [Related]

  • 2. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
    Raap DK, Evans S, Garcia F, Li Q, Muma NA, Wolf WA, Battaglia G, Van De Kar LD.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
    [Abstract] [Full Text] [Related]

  • 3. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
    Li Q, Muma NA, van de Kar LD.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1035-42. PubMed ID: 8930214
    [Abstract] [Full Text] [Related]

  • 4. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN, Zhang Y, Garcia F, Battaglia G, Van De Kar LD.
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [Abstract] [Full Text] [Related]

  • 5. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors.
    Li Q, Muma NA, Battaglia G, Van de Kar LD.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1581-90. PubMed ID: 9316875
    [Abstract] [Full Text] [Related]

  • 6. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
    Serres F, Muma NA, Raap DK, Garcia F, Battaglia G, Van de Kar LD.
    J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
    [Abstract] [Full Text] [Related]

  • 7. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
    D'Souza DN, Zhang Y, Garcia F, Battaglia G, Van de Kar LD.
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.
    Zhang Y, D'Souza D, Raap DK, Garcia F, Battaglia G, Muma NA, Van de Kar LD.
    J Neurosci; 2001 Oct 15; 21(20):7919-27. PubMed ID: 11588165
    [Abstract] [Full Text] [Related]

  • 9. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD, Raap DK, Battaglia G, Muma NA, Garcia F, DonCarlos LL.
    Neuropharmacology; 2002 Jul 15; 43(1):45-54. PubMed ID: 12213258
    [Abstract] [Full Text] [Related]

  • 10. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo.
    Serres F, Li Q, Garcia F, Raap DK, Battaglia G, Muma NA, Van de Kar LD.
    J Neurosci; 2000 May 01; 20(9):3095-103. PubMed ID: 10777773
    [Abstract] [Full Text] [Related]

  • 11. Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.
    Li Q, Sullivan NR, McAllister CE, Van de Kar LD, Muma NA.
    Psychoneuroendocrinology; 2013 Jul 01; 38(7):1145-57. PubMed ID: 23219224
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN, Zhang Y, Damjanoska KJ, Carrasco GA, Sullivan NR, Garcia F, Battaglia G, Doncarlos LL, Muma NA, Van de Kar LD.
    Neuroendocrinology; 2004 Jul 01; 80(1):31-41. PubMed ID: 15385710
    [Abstract] [Full Text] [Related]

  • 16. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
    Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G, Van de Kar LD.
    Brain Res; 1993 Dec 10; 630(1-2):148-56. PubMed ID: 8118681
    [Abstract] [Full Text] [Related]

  • 17. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
    Kantor S, Graf M, Anheuer ZE, Bagdy G.
    Eur Neuropsychopharmacol; 2001 Feb 10; 11(1):15-24. PubMed ID: 11226808
    [Abstract] [Full Text] [Related]

  • 18. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A, Li Q, Battaglia G, Van de Kar LD.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC.
    J Pharmacol Exp Ther; 2000 Aug 10; 294(2):688-700. PubMed ID: 10900249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.